130 related articles for article (PubMed ID: 7466730)
1. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
[No Abstract] [Full Text] [Related]
2. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
[No Abstract] [Full Text] [Related]
3. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
[TBL] [Abstract][Full Text] [Related]
4. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
[No Abstract] [Full Text] [Related]
5. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
6. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
7. [Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile].
Drouin P; Sauvanet JP; Demange J; Lambert L; Debry G
Nouv Presse Med; 1980 Nov; 9(42):3186. PubMed ID: 7443475
[No Abstract] [Full Text] [Related]
8. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
Kusić M; Gavrilović M; Mihajlović M; Bosković B
Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
[No Abstract] [Full Text] [Related]
10. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
Kuo PT; Kostis JB; Moreyra AE; Hayes JA
Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
[TBL] [Abstract][Full Text] [Related]
11. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
12. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
13. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
Briones ER; Steiger D; Palumbo PJ; Kottke BA
Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603
[TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic activity of colestipol in diabetes.
Bandisode MS; Boshell BR
Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
[No Abstract] [Full Text] [Related]
15. [Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
Morimoto Y
Horumon To Rinsho; 1981 Feb; 29(2):237-43. PubMed ID: 7261445
[No Abstract] [Full Text] [Related]
16. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
17. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
[TBL] [Abstract][Full Text] [Related]
18. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
Düntsch G
Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
[TBL] [Abstract][Full Text] [Related]
19. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
[TBL] [Abstract][Full Text] [Related]
20. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
